Shareholders are gearing up for a long-awaited trial this week as they seek £600 million (US$794.8 million) in damages from Lloyds Banking Group and five former executives over claims they were misled during the acquisition of HBOS.
Opening submissions are set to be given at the Royal Courts of Justice on Wednesday, October 18, marking the start of a 14-week trial brought by the Lloyds/HBOS Shareholder Action Group.
The group – which represents about 6,000 former Lloyds TSB shareholders – is seeking around £600 million (US$794.8 million) in damages in the case against Lloyds Banking Group, former chairman Sir Victor Blank, ex-chief executive Eric Daniels, former chief financial officer Tim Tookey, one-time director of retail banking Helen Weir, and ex-director of wholesale banking George Truett Tate.
It is expected that each defendant will be cross-examined during the trial, which is expected to shed further light on the internal decisions that drove the bank’s controversial acquisition of HBOS.
HBOS saddled Lloyds with lots of toxic assets stemming from risky bets made by HBOS on commercial property during the boom years.
Lloyds was later forced to take a Government bailout worth £20.3 billion (US$26.9 billion), which has been blamed in part on the takeover.
Full Content: Insider
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas